No Data
No Data
Leerink Partners Maintains Illumina(ILMN.US) With Buy Rating, Announces Target Price $115
Bernstein Maintains Illumina(ILMN.US) With Hold Rating, Cuts Target Price to $90
Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
Express News | Illumina Inc : Bernstein Cuts Target Price to $90 From $130
Illumina And Tempus AI Collaborate To Accelerate Clinical Adoption Of Next-generation Sequencing Tests Through Novel Evidence Generation
Illumina and Tempus Partner to Drive the Future of Precision Medicine Through Genomic AI Innovation